Pharmena S.A. (WAR:PHR) — Stock Price
Pharmena S.A. (WAR:PHR) is currently trading at zł3.07 PLN, up 0.33% today. Over the past 52 weeks, shares have ranged between zł2.55 and zł4.22. This page tracks Pharmena S.A.'s live share price on the WAR exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see PHR stock market capitalisation.
Pharmena S.A. (PHR) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Pharmena S.A.'s daily closing share price and trading volume on the WAR exchange over the past year, giving a clear view of recent price momentum and liquidity.
Pharmena S.A. Income Statement — Revenue, Profit & Earnings by Year
Pharmena S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | zł268.00K | zł9.84 Million | zł299.00K | zł15.21 Million | zł9.93 Million |
| Cost of Revenue | zł70.00K | zł3.99 Million | zł8.69 Million | zł7.38 Million | zł4.85 Million |
| Gross Profit | zł198.00K | zł5.84 Million | zł10.34 Million | zł7.83 Million | zł5.08 Million |
| Research & Development | zł10.00K | — | zł153.00K | zł133.00K | — |
| SG&A | zł2.95 Million | zł3.59 Million | zł3.23 Million | zł4.68 Million | zł3.98 Million |
| Total Operating Expenses | zł3.60 Million | zł-29.03 Million | zł10.85 Million | zł11.84 Million | zł11.12 Million |
| Operating Income | zł-3.40 Million | zł34.87 Million | zł-508.00K | zł-3.98 Million | zł-6.04 Million |
| EBITDA | zł-3.38 Million | zł35.55 Million | zł-129.00K | zł-3.52 Million | zł-5.40 Million |
| EBIT | zł-3.40 Million | zł35.23 Million | zł-690.00K | zł-4.14 Million | zł-6.03 Million |
| Interest Expense | — | zł530.00K | zł722.00K | zł265.00K | zł204.00K |
| Income Before Tax | zł-2.56 Million | zł34.86 Million | zł-4.95 Million | zł-4.46 Million | zł-6.27 Million |
| Income Tax Expense | zł-1.29 Million | zł5.91 Million | zł204.00K | zł182.00K | zł686.00K |
| Net Income | zł-1.26 Million | zł28.94 Million | zł-1.57 Million | zł-4.59 Million | zł-6.89 Million |
Pharmena S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Pharmena S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | zł13.53 Million | zł24.13 Million | zł12.58 Million | zł11.15 Million | zł10.95 Million |
| Total Current Assets | zł11.88 Million | zł23.33 Million | zł9.97 Million | zł8.20 Million | zł8.26 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | — | zł380.00K | — | — |
| Net Receivables | zł76.00K | zł305.00K | zł3.81 Million | zł3.20 Million | zł2.41 Million |
| Inventory | zł689.00K | zł445.00K | zł4.56 Million | zł3.46 Million | zł4.00 Million |
| Property, Plant & Equipment | — | — | zł498.00K | zł808.00K | zł435.00K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | zł1.11 Million | zł1.91 Million | zł19.37 Million | zł16.27 Million | zł11.30 Million |
| Total Current Liabilities | zł915.00K | zł1.77 Million | zł16.97 Million | zł11.58 Million | zł11.13 Million |
| Long-term Debt | — | — | — | — | zł137.00K |
| Net Debt | zł-1.50 Million | zł-22.06 Million | zł-1.08 Million | zł-678.00K | zł-1.33 Million |
| Total Stockholder Equity | zł12.42 Million | zł22.52 Million | zł-6.49 Million | zł-4.87 Million | zł-139.00K |
| Retained Earnings | zł-1.26 Million | zł-22.99 Million | zł-51.93 Million | zł-50.36 Million | zł-56.15 Million |
Pharmena S.A. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Pharmena S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | zł-2.53 Million | zł33.03 Million | zł1.82 Million | zł-3.23 Million | zł-2.24 Million |
| Capital Expenditures | zł180.00K | zł314.00K | zł226.00K | zł319.00K | zł214.00K |
| Free Cash Flow | zł-2.71 Million | zł32.72 Million | zł1.59 Million | zł-3.54 Million | zł-2.46 Million |
| Investing Cash Flow | zł-8.36 Million | zł-3.13 Million | zł-219.00K | zł-248.00K | zł-198.00K |
| Financing Cash Flow | zł-9.54 Million | zł-9.26 Million | zł-1.47 Million | zł3.21 Million | zł3.12 Million |
| Dividends Paid | zł9.47 Million | — | — | — | — |
| Stock-Based Compensation | — | — | — | — | — |
| Depreciation | zł95.00K | zł325.00K | zł561.00K | zł626.00K | zł628.00K |
| Change in Cash | zł-20.49 Million | zł20.64 Million | zł132.00K | zł-262.00K | zł674.00K |
Pharmena S.A. Earnings History — EPS Actual vs. Analyst Estimates
Track Pharmena S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 25, 2026 | — | — | — |
| Mar 30, 2026 | — | — | — |
| Nov 24, 2025 | — | — | — |
| Aug 25, 2025 | — | — | — |
| May 26, 2025 | — | — | — |
| Feb 26, 2025 | — | — | — |
| Nov 25, 2024 | -0.04 | — | — |
| Aug 26, 2024 | -0.08 | — | — |